Announcement of TTY Biopharm's unaudited income information in December 2022

Announcement of TTY Biopharm's unaudited income information in December 2022

2023.1.16

...

More

Announcement of TTY Biopharm's unaudited income information in November 2022

Announcement of TTY Biopharm's unaudited income information in November 2022

2022.12.12

...

More

TTY Biopharm Receives Market Approval For The New Sedative In Procedural Sedation In Taiwan

TTY Biopharm Receives Market Approval For The New Sedative In Procedural Sedation In Taiwan

2022.11.14

...

More

Announcement of TTY Biopharm's unaudited income information in October 2022

Announcement of TTY Biopharm's unaudited income information in October 2022

2022.11.11

...

More

Announcement of The Consolidated Financial Report for The 3rd Quarter of 2022

Announcement of The Consolidated Financial Report for The 3rd Quarter of 2022

2022.11.4

...

More

Announcement of TTY Biopharm's unaudited income information in September 2022

Announcement of TTY Biopharm's unaudited income information in September 2022

2022.10.11

...

More

Announcement of TTY Biopharm's unaudited income information in August 2022

Announcement of TTY Biopharm's unaudited income information in August 2022

2022.9.13

...

More

Announcement of TTY Biopharm's unaudited income information in July 2022

Announcement of TTY Biopharm's unaudited income information in July 2022

2022.8.11

...

More

TTY, Everest form exclusive partnership to introduce to Taiwan a new drug for treating multiple-drug-resistant infection

TTY, Everest form exclusive partnership to introduce to Taiwan a new drug for treating multiple-drug-resistant infection

2022.8.11

...

More

Announcement of The Consolidated Financial Report for The 2nd Quarter of 2022

Announcement of The Consolidated Financial Report for The 2nd Quarter of 2022

2022.8.5

...

More

TOP